Lapu-Lapu City Hospital pioneers advanced imaging in gallbladder surgery
Lapu-Lapu City Hospital pioneers advanced imaging in gallbladder surgery
Lapu-Lapu City Hospital pioneers advanced imaging in gallbladder surgery
Lapu-Lapu City Hospital has successfully performed its first intraoperative cholangiography using a new C-arm fluoroscopy machine. The procedure took place during a cholecystectomy on February 8, 2026, marking a significant upgrade in the hospital's surgical capabilities.
The hospital acquired the C-arm fluoroscopy machine as part of the City Government's healthcare improvement programme. The technology allows surgeons to view real-time images during operations, increasing precision and patient safety.
This was not the first time the machine had been used. The hospital had previously carried out a major orthopaedic surgery with the same imaging system. However, its application in general surgery—such as the recent cholecystectomy—represents a new milestone.
While no numerical data on outcomes is yet available, doctors have noted qualitative benefits. The real-time imaging helps guide surgical decisions, reducing risks during complex procedures.
The introduction of C-arm fluoroscopy strengthens Lapu-Lapu City's healthcare services. Surgeons can now perform safer and more accurate operations in both orthopaedic and general procedures. The technology is expected to become a standard tool in future surgeries at the hospital.
Geesthacht Hospital shifts to specialist clinic after financial crisis and staff shortages
A once-full-service hospital now fights for survival. How Geesthacht's bold downsizing could redefine local healthcare—or leave patients scrambling.
National health hotline cuts wait times with 24/7 support and AI upgrades
Struggling with long-term illness? This free hotline now answers faster—thanks to AI and smarter systems. See how it's changing patient care.
Novartis bets $3B on unproven breast cancer therapy SNV4818
A $3B gamble on an untested drug could redefine breast cancer care—or backfire. Why Novartis is banking on SNV4818's untapped potential before clinical trials even begin.
How prior authorization delays can harm patients and frustrate doctors
A system meant to cut costs is putting patients at risk. Doctors warn that insurance red tape is delaying care—and even forcing dangerous medication switches.